# Cresco Labs Inc. (CRLBF)

> Source: Nexqual · https://nexqual.com/CRLBF · data as of 2026-10-23 20:00 UTC · cite as "Nexqual, Cresco Labs Inc. (CRLBF), nexqual.com/CRLBF" · informational, not investment advice.

**Price:** USD 0.6 (-5.51% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 0.64 · day 0.6–0.63 · 52w 0.57–2.3 · market cap $222M · OQX

## Key facts
- Analysts: Buy (mean 1.83 on a 1–5 scale) (6 analysts), mean target USD 2 (range 2–2).
- Total return with dividends: 1Y -50.8% vs S&P 500 +13.4%; 5Y -92.3% vs S&P 500 +76.9%.
- Next earnings: 2026-11-06, EPS estimate USD -0.03, revenue estimate $174M.

## Analysts
Consensus Buy (mean 1.83 on a 1–5 scale), 6 analysts; mean target USD 2 (low 2, high 2).

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | -50.8% | -92.3% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -50.9% | -40.2% |
| Volatility (annualized) | 121.8% | 87.8% |
| Max drawdown | -69.9% (Dec 2025→Oct 2026) | -95.5% (Nov 2021→Jun 2025) |

## Peers (Drug Manufacturers - Specialty & Generic)
BHC (Bausch Health Companies Inc.) USD 6.44 -0.77% · HCM (HUTCHMED (China) Limited) USD 14.36 +0.56% · AMLX (Amylyx Pharmaceuticals, Inc.) USD 27.2 -4.80% · LQDA (Liquidia Corporation) USD 42.65 +7.46% · RGC (Regencell Bioscience Holdings L) USD 7.67 -21.81% · INDV (Indivior Pharmaceuticals, Inc.) USD 34.47 -2.43%

## More
Full page: https://nexqual.com/CRLBF · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $-0.03 | $0.00 | — | $173.7M | 1 |
| Next quarter (ends 2026-12-31) | $-0.03 | $0.00 | — | $173.9M | 1 |
| Current fiscal year (ends 2026-12-31) | $-0.04 | $-0.09 | -56.2% | $672.2M | 1 |
| Next fiscal year (ends 2027-12-31) | $-0.04 | $-0.06 | -35.0% | $697.5M | 1 |